Relay Therapeutics Inc is trading 4.5% up at $14.28 in pre-market, extending a technical rebound following last week's rate-driven selloff in the biotech sector.
- The stock is continuing Monday's upward momentum as risk sentiment improves across growth and biotech shares.
- Broader U.S. equity futures are trading higher, providing additional support for the pre-market gains.
- There are no new company-specific filings or news releases today, suggesting the move is driven by broader market dynamics.